Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

Celgene Corp (NASDAQ: CELG)

$125.20 USD -$0.32 (-0.25%)
Last Price $125.2
Net Change $-0.32 (-0.25%)
Bid $125.2
Ask Price $125.76
Open Price $126.26
Previous Close Price $125.52
High Price $126.53
Low Price $125.06
Number of Trades 18,378
Volume 3,628,902
Fifty Two Week High $127.64 (2017-03-17)
Fifty Two Week Low $94.42 (2016-06-27)
Average Daily Volume 3,914,359
Share Outstanding 777,970 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $1.61 (2017-01-26)
2nd Quarter Earnings $1.58 (2016-10-27)
3nd Quarter Earnings $1.44 (2016-07-28)
4th Quarter Earnings $1.32 (2016-04-28)
PE Ratio $23.41
EPS Growth $26.74
Recent Earnings $1.61
Annual EPS $5.26
Last Quarter EPS $
Market Capitalization $97.40B
Insider Shareholders % 0.0097%
Annual Revenue $0B
No. Shares Outstanding 777,970
Inst. Shareholder % 77.68%
Annual Net Income $0B
TTM Net Profit Margin $686.79
1-Year Return 16.71%
3-Year Return 75.84%
5-Year Return 242.11%
5-Year Revenue Growth 131.91%
5-Year Earnings Growth 201.16%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD 26.74%
Dividends per Share $
Stock Split Ratio 2-1
Beta 1.78
Celgene Corp. is an independent biopharmaceutical company engaged primarily in the discovery, development and commercialization of orally administered, small molecule drugs for the treatment of cancer and immunological diseases.